Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients

…, Y Hirasawa, H Ariizumi, T Tsunoda, T Ikusue… - Cancer Chemotherapy …, 2020 - Springer
Purpose Capecitabine is a prodrug that undergoes metabolism in three steps to form an
active 5-fluorouracil (5-FU). The first step is primarily catalyzed by liver carboxylesterases (CES) …

[HTML][HTML] Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX

…, Y Kubota, T Tagawa, T Yamamoto, T Ikusue… - Oncotarget, 2016 - ncbi.nlm.nih.gov
There are several reports on the correlation between early tumor shrinkage (ETS) or depth of
response (DpR) and survival in chemotherapies for colorectal cancer; however, few studies …

Acute appendicitis with a neuroendocrine tumor G1 (carcinoid): pitfalls of conservative treatment

…, T Fujimoto, Y Kato, M Sasaki, T Ikusue - Clinical journal of …, 2016 - Springer
A man in his early thirties presented to our clinic with right lower abdominal pain. Computed
tomography (CT) and ultrasonography (US) revealed a swollen appendix and an …

Tolerability and clinical outcomes in elderly patients with advanced pancreatic cancer treated with FOLFIRINOX.

…, Y Sunakawa, Y Kubota, T Tagawa, Y Kaga, T Ikusue… - 2016 - ascopubs.org
404 Background: FOLFIRINOX, a combination chemotherapy of 5-FU, oxaliplatin, and irinotecan,
has contributed to the overall survival (OS) benefit of advanced pancreatic cancer (PC), …

VEGF inhibitors do not increase d-dimer levels in colorectal cancer patients without venous thromboembolism: A retrospective non-inferiority analysis

H Toshima, T Ikusue, A Hisamatsu, K Kobayashi… - in vivo, 2019 - iv.iiarjournals.org
Background/Aim: If VEGF inhibitors contribute to an increase in D-dimer levels, they may
adversely affect the diagnosis of venous thromboembolism (VTE). Consequently, this …

Two cases of lymphangitic carcinomatosis as the primary symptom of colorectal carcinoma that achieved complete remission using combination anti-EGFR antibody …

H Toshima, T Ikusue, A Hisamatsu… - OncoTargets and …, 2019 - Taylor & Francis
Clinicians often encounter cases of pulmonary lymphangitic carcinomatosis when treating
patients with cancer. When such a condition develops before the diagnosis of cancer, its …

A pooled analysis of the secondary resection for colorectal cancer liver metastases: Comparison of bevacizumab (Bmab) and anti-EGFRs.

W Ichikawa, Y Sunakawa, H Nakayama, T Ikusue… - 2016 - ascopubs.org
610 Background: Systemic chemotherapies can convert irresectable liver metastases (LM)
to resectable in some cases of metastatic colorectal cancer (mCRC). Secondary surgical …

Early tumor shrinkage as a predictor of favorable outcomes in patients (pts) with advanced pancreatic cancer treated with FOLFIRINOX.

…, Y Kubota, T Tagawa, T Yamamoto, T Ikusue… - 2016 - ascopubs.org
237 Background: Results from the phase III PRODIGE 4/ACCORD 11 trial provided one of
current standard regimens for advanced pancreatic cancer (PC), consisting of oxaliplatin, …

[HTML][HTML] Neuroendocrine tumor of the appendix masquerading as acute appendicitis with a mucocele on CT scan: a rare finding

AS Al-Darwish, WR Alsubaie, W AlShammari… - Surgical Case …, 2024 - Springer
Introduction Neuroendocrine tumors (NETs) of the appendix are rare and are often discovered
incidentally during surgery for acute appendicitis or other unrelated conditions (Modlin et …

Baba, Hideo LBA-003 Babu, Suresh P-277 Bachet, Jean-Baptiste O-002, P-086, P-362 Bae, Junghoon P-204 Baertschi, Daniela PD-021

UP Ahmad, VP Aiello-Crocifoglio, KP Akagi… - annalsofoncology.org
Ikusue, Toshikazu P-336 … Moriwaki, Toshikazu O-012 …